what role will erdafitinib play in treating metastatic urothelial carcinoma?
Published 1 year ago • 40 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
1:49
blc2001: erdafitinib for the treatment of metastatic urothelial carcinoma
-
1:28
erdafitinib for bladder cancer: more to come following fda approval
-
2:12
erdafitinib: one more tool for bladder cancer
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
4:43
erdafitinib for fgfr-mutated urothelial carcinoma
-
3:37
optimal treatment strategies for patients with metastatic urothelial carcinoma
-
1:17
recent advances in the treatment of upper tract urothelial carcinoma
-
3:02
discussion on trial investigating erdafitinib in patients with urothelial cancer
-
0:37
bladder-sparing approaches in muscle-invasive urothelial carcinoma
-
0:57
dr. siefker-radtke on next steps with erdafitinib in bladder cancer
-
1:28
immune checkpoint inhibitors and sitravatinib in bladder cancer
-
2:35
urothelial carcinoma treatment: the future
-
2:03
the evolution of bladder cancer treatment and the immuno-oncology era
-
2:29
survival trends: urothelial vs. nonurothelial bladder cancer
-
3:14
the role of enfortumab vedotin in earlier lines and stages of urothelial cancer | arjun balar
-
1:47
current and upcoming clinical trials in bladder cancer
-
4:46
changing the standard of care in metastatic bladder cancer
-
0:40
what is the main cause of bladder cancer? by dr. michael daneshvar - uc irvine department of urology